Cargando…
Pharmacokinetics of Equol, a Soy Isoflavone Metabolite, Changes with the Form of Equol (Dietary versus Intestinal Production) in Ovariectomized Rats
[Image: see text] Recent findings indicate that soy isoflavones and their metabolites may play a role in mitigating postmenopausal bone loss. Equol, a metabolite of the soy isoflavone daidzein produced by intestinal bacteria, has shown some potential, but only 30–50% of the U.S. population is capabl...
Autores principales: | Legette, LeeCole L., Prasain, Jeevan, King, Jennifer, Arabshahi, Ali, Barnes, Stephen, Weaver, Connie M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983397/ https://www.ncbi.nlm.nih.gov/pubmed/24446705 http://dx.doi.org/10.1021/jf400097m |
Ejemplares similares
-
Effect of S-equol and Soy Isoflavones on Heart and Brain
por: Sekikawa, Akira, et al.
Publicado: (2019) -
Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia
por: Sekikawa, Akira, et al.
Publicado: (2022) -
Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases—From Molecular Mechanisms to Studies in Humans
por: Zhang, Xiao, et al.
Publicado: (2021) -
A Systematic Review of the Effects of Equol (Soy Metabolite) on Breast Cancer
por: Hod, Rafidah, et al.
Publicado: (2021) -
Metabolism of Soy Isoflavones by Intestinal Bacteria: Genome Analysis of an Adlercreutzia equolifaciens Strain That Does Not Produce Equol
por: Vázquez, Lucía, et al.
Publicado: (2020)